Goldman Sachs’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $98.4M | Buy |
1,088,213
+69,794
| +7% | +$6.4M | 0.01% | 1042 |
|
|
2025
Q4 | $91.6M | Buy |
1,018,419
+199,478
| +24% | +$18.9M | 0.01% | 1052 |
|
|
2025
Q3 | $80.7M | Buy |
818,941
+348,532
| +74% | +$34.5M | 0.01% | 1084 |
|
|
2025
Q2 | $42.9M | Sell |
470,409
-180,093
| -28% | -$17.4M | 0.01% | 1444 |
|
|
2025
Q1 | $73.6M | Sell |
650,502
-163,668
| -20% | -$17.5M | 0.01% | 967 |
|
|
2024
Q4 | $86M | Sell |
814,170
-813,019
| -50% | -$87.2M | 0.01% | 894 |
|
|
2024
Q3 | $176M | Sell |
1,627,189
-820,428
| -34% | -$89.5M | 0.03% | 564 |
|
|
2024
Q2 | $266M | Buy |
2,447,617
+158,529
| +7% | +$18.7M | 0.04% | 426 |
|
|
2024
Q1 | $302M | Buy |
2,289,088
+453,099
| +25% | +$56.6M | 0.05% | 360 |
|
|
2023
Q4 | $223M | Buy |
1,835,989
+79,732
| +5% | +$8.9M | 0.04% | 450 |
|
|
2023
Q3 | $197M | Sell |
1,756,257
-51,215
| -3% | -$6.5M | 0.04% | 436 |
|
|
2023
Q2 | $263M | Buy |
1,807,472
+44,319
| +3% | +$6.02M | 0.06% | 332 |
|
|
2023
Q1 | $228M | Buy |
1,763,153
+270,027
| +18% | +$33.9M | 0.05% | 375 |
|
|
2022
Q4 | $190M | Buy |
1,493,126
+147,934
| +11% | +$17.2M | 0.05% | 433 |
|
|
2022
Q3 | $141M | Buy |
1,345,192
+183,819
| +16% | +$20.2M | 0.04% | 526 |
|
|
2022
Q2 | $122M | Sell |
1,161,373
-28,984
| -2% | -$3.44M | 0.03% | 598 |
|
|
2022
Q1 | $152M | Buy |
1,190,357
+77,225
| +7% | +$9.31M | 0.03% | 537 |
|
|
2021
Q4 | $137M | Sell |
1,113,132
-206,069
| -16% | -$27M | 0.03% | 633 |
|
|
2021
Q3 | $187M | Buy |
1,319,201
+4,779
| +0.4% | +$703K | 0.04% | 441 |
|
|
2021
Q2 | $205M | Sell |
1,314,422
-27,017
| -2% | -$4.38M | 0.05% | 392 |
|
|
2021
Q1 | $208M | Buy |
1,341,439
+67,686
| +5% | +$10.5M | 0.05% | 358 |
|
|
2020
Q4 | $191M | Sell |
1,273,753
-455,637
| -26% | -$64.4M | 0.05% | 347 |
|
|
2020
Q3 | $229M | Buy |
1,729,390
+184,709
| +12% | +$24.1M | 0.06% | 296 |
|
|
2020
Q2 | $179M | Sell |
1,544,681
-138,275
| -8% | -$15.9M | 0.05% | 339 |
|
|
2020
Q1 | $165M | Sell |
1,682,956
-172,669
| -9% | -$22.6M | 0.06% | 323 |
|
|
2019
Q4 | $270M | Buy |
1,855,625
+70,883
| +4% | +$9.78M | 0.07% | 307 |
|
|
2019
Q3 | $238M | Buy |
1,784,742
+104,631
| +6% | +$13.5M | 0.07% | 314 |
|
|
2019
Q2 | $192M | Sell |
1,680,111
-325,870
| -16% | -$38.2M | 0.06% | 384 |
|
|
2019
Q1 | $249M | Buy |
2,005,981
+238,925
| +14% | +$27.2M | 0.08% | 271 |
|
|
2018
Q4 | $178M | Buy |
1,767,056
+198,263
| +13% | +$22.3M | 0.06% | 355 |
|
|
2018
Q3 | $200M | Sell |
1,568,793
-66,924
| -4% | -$7.96M | 0.05% | 414 |
|
|
2018
Q2 | $177M | Sell |
1,635,717
-809,048
| -33% | -$88.1M | 0.05% | 452 |
|
|
2018
Q1 | $259M | Sell |
2,444,765
-8,913
| -0.4% | -$1.04M | 0.07% | 321 |
|
|
2017
Q4 | $287M | Buy |
2,453,678
+1,225,922
| +100% | +$139M | 0.07% | 317 |
|
|
2017
Q3 | $140M | Sell |
1,227,756
-59,776
| -5% | -$6.9M | 0.03% | 614 |
|
|
2017
Q2 | $161M | Sell |
1,287,532
-116,944
| -8% | -$13.9M | 0.04% | 506 |
|
|
2017
Q1 | $167M | Sell |
1,404,476
-53,318
| -4% | -$6.04M | 0.05% | 461 |
|
|
2016
Q4 | $146M | Buy |
1,457,794
+182,660
| +14% | +$19.6M | 0.04% | 543 |
|
|
2016
Q3 | $161M | Sell |
1,275,134
-1,095,619
| -46% | -$135M | 0.05% | 446 |
|
|
2016
Q2 | $277M | Sell |
2,370,753
-3,517,885
| -60% | -$398M | 0.09% | 217 |
|
|
2016
Q1 | $610M | Sell |
5,888,638
-27,237,371
| -82% | -$2.63B | 0.2% | 77 |
|
|
2015
Q4 | $3.3B | Buy |
33,126,009
+27,951
| +0.1% | +$2.73M | 1.04% | 5 |
|
|
2015
Q3 | $3.02B | Sell |
33,098,058
-77,149
| -0.2% | -$7.73M | 1.02% | 5 |
|
|
2015
Q2 | $3.52B | Buy |
33,175,207
+30,895,032
| +1,355% | +$3.42B | 1.09% | 4 |
|
|
2015
Q1 | $260M | Sell |
2,280,175
-52,133
| -2% | -$5.95M | 0.08% | 257 |
|
|
2014
Q4 | $257M | Buy |
2,332,308
+155,410
| +7% | +$16.4M | 0.08% | 273 |
|
|
2014
Q3 | $213M | Sell |
2,176,898
-167,851
| -7% | -$16.5M | 0.07% | 310 |
|
|
2014
Q2 | $236M | Buy |
2,344,749
+1,705,094
| +267% | +$166M | 0.07% | 292 |
|
|
2014
Q1 | $58.7M | Buy |
639,655
+39,311
| +7% | +$3.62M | 0.02% | 933 |
|
|
2013
Q4 | $54.3M | Sell |
600,344
-10,069
| -2% | -$871K | 0.02% | 985 |
|
|
2013
Q3 | $48.7M | Buy |
610,413
+121,379
| +25% | +$9.55M | 0.02% | 977 |
|
|
2013
Q2 | $35.6M | Buy |
+489,034
| New | +$36.6M | 0.01% | 1120 |
|
Other funds holding ZBH
VCM
VPM
Goldman Sachs's ZBH Position: Q1 2026 in Review
Goldman Sachs increased its Zimmer Biomet (ZBH) stake by 6.9% in Q1 2026, buying an estimated $6.4M and bringing the position to 1,088,213 shares worth $98.4M. The position accounts for 0.01% of the portfolio, ranked #1042.
Goldman Sachs first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.52B in Q2 2015. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Goldman Sachs held 1,088,213 shares of Zimmer Biomet worth $98.4M as of Q1 2026.
- Goldman Sachs bought 69,794 Zimmer Biomet shares in Q1 2026, an estimated $6.4M.
- Zimmer Biomet made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1042 holding.
- Goldman Sachs first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Zimmer Biomet position peaked at $3.52B in Q2 2015.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.